Part B Drug Payment Reform: Lower Expenditures Without Signs of Adverse Effects

Part B Drug Payment Reform: Lower Expenditures Without Signs of Adverse Effects

Published: Aug 28, 2009
Publisher: Princeton, NJ: Mathematica Policy Research
Download
Authors

Jeffrey Ballou

Valerie Cheh

Bonnie Hart

Joshua Parks

John Hall

Research found that physicians were being reimbursed far in excess of what they were paying for Part B drugs and that there was little incentive in the Medicare payment system to contain drug expenditures.

How do you apply evidence?

Take our quick four-question survey to help us curate evidence and insights that serve you.

Take our survey